Meta-analysis: diagnostic accuracy of anti-cyclic citrullinated peptide 2 antibody and anti-cyclic citrullinated peptide 3 antibody in rheumatoid arthritis
Meta-analysis: diagnostic accuracy of anti-cyclic citrullinated peptide 2 antibody and anti-cyclic citrullinated peptide 3 antibody in rheumatoid arthritis
复制标题
Meta分析:抗环瓜氨酸肽2抗体和抗环瓜氨酸肽3抗体在类风湿性关节炎中的诊断准确性
DOI:
10.1515/cclm-2013-0798
复制
发表时间:
2014-06
影响因子:
6.8
通讯作者:
Chen Wei-Xian
中科院分区:
文献类型:
--
作者:
Zhang Wen-Chao;Wu Han;Chen Wei-Xian
Abstract The aim of this work was to assess the diagnostic value of anti-CCP-3 and anti-CCP-2 for the diagnosis of rheumatoid arthritis (RA) and determine whether anti-CCP-3 more accurately identifies patients with rheumatoid arthritis than anti-CCP-2. PubMed and CNKI databases were searched for studies published in English and Chinese that examined the use of anti-CCP-3 and anti-CCP-2 in the diagnosis of known or suspected rheumatoid arthritis from January 2006 to July 2013. Seventeen included studies of methodological quality were rated by using the Quality Assessment of Diagnostic Accuracy Studies (QUADAS) tools A random-effects method was used to summarize sensitivities, specificities, positive and negative likelihood ratio (LR+ and LR−, respectively), and diagnostic odds ratio from 17 studies. The pooled sensitivity, specificity, LR+, LR− and diagnostic odds ratio for anti-CCP-3 were 0.737 (95% CI, 0.717–0.757), 0.933 (95% CI, 0.924–0.942), 11.096 (95% CI, 8.876–13.870), 0.274 (95% CI, 0.231–0.326), and 42.908 (95% CI, 33.828–54.426), respectively. For anti-CCP-2, the values were 0.719 (95% CI, 0.699–0.739), 0.960 (95% CI, 0.953–0.966), 17.485 (95% CI, 11.960–25.562), 0.294 (95% CI, 0.258–0.335) and 63.458 (95% CI, 44.214–91.078), respectively. With high specificity and moderate sensitivity, anti-CCP-2 and anti-CCP-3 played an important role in confirming the diagnosis of RA. Anti-CCP-3 did not have better diagnostic performances than anti-CCP-2, but anti-CCP-2 had evident heterogeneity compared to anti-CCP-3, especially in American patients.
登录
查看更多内容
影响因子:
4
作者:
Shidara, Kumi;Inoue, Eisuke;Yamanaka, Hisashi
通讯作者:
Yamanaka, Hisashi
影响因子:
27.4
作者:
Cruyssen, B. Vander;Nogueira, L.;De Keyser, F.
通讯作者:
De Keyser, F.
DOI:
10.1186/ar395
发表时间:
2002
期刊:
Arthritis research
影响因子:
--
作者:
van Boekel MA;Vossenaar ER;van den Hoogen FH;van Venrooij WJ
通讯作者:
van Venrooij WJ
影响因子:
9.1
作者:
M. Elrefaei;Kristie Boose;Martha McGee;T. Tarrant;F. Lin;J. Fine;J. Schmitz
通讯作者:
M. Elrefaei;Kristie Boose;Martha McGee;T. Tarrant;F. Lin;J. Fine;J. Schmitz
影响因子:
3.4
作者:
J. Rojas-Serrano;R. Burgos-Vargas;Leticia Lino Pérez;C. García García-C.-García-García-49141962;Francisco Moctezuma;J. Vázquez-Mellado
通讯作者:
J. Rojas-Serrano;R. Burgos-Vargas;Leticia Lino Pérez;C. García García-C.-García-García-49141962;Francisco Moctezuma;J. Vázquez-Mellado